(Q21195084)

Dimensions Publication ID

Dimensions

1023944711

18 August 2022

Hae Won Kim

series ordinal

2

author given names

Hae Won

author last names

Kim

1 reference

Dimensions Publication ID

Dimensions

1023944711

Hb-based oxygen carriers: are we there yet?

18 August 2022

language of work or name

English

0 references

publication date

2004

0 references

14 June 2004

1 reference

1 October 2019

1 reference

1 October 2019

8 Suppl 2

0 references

issue

Suppl 2

0 references

page(s)

S61-4

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Blood substitutes and oxygen therapeutics: an overview and current status

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Blood substitutes in surgery

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226150

Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial

29 November 2018

1 reference

12 December 2020

Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure

1 reference

12 December 2020

A phase I study of oxidized raffinose cross-linked human hemoglobin

1 reference

12 December 2020

A physiologic basis for red blood cell transfusion decisions

1 reference

12 December 2020